Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference5 articles.
1. Permethrin-resistant scabies;Med Clin (Barc),2024
2. Resistance and pseudo-resistance to permethrin: the importance of controlling scabies;Front Cell Infect Microbiol,2023
3. Failure of scabies treatment: a systematic review and meta-analysis;Br J Dermatol,2024
4. Permethrin-unresponsive scabies in London, UK: a wake-up call;Clin Exp Dermatol,2023
5. Comparison of topical 5% permethrin vs. 25% benzyl benzoate in treating scabies—a double-blinded, randomized controlled study;Br J Dermatol,2023